MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adan, R. A.
Right arrow Articles by Gispen, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adan, R. A.
Right arrow Articles by Gispen, W. H.

Differential effects of melanocortin peptides on neural melanocortin receptors

RA Adan, RD Cone, JP Burbach and WH Gispen

Rudolf Magnus Institute for Neuroscience, Department of Medical Pharmacology, Utrecht University, The Netherlands.

Melanocortins (MCs) have various physiological actions on the brain. The recent cloning of neural MC receptors opened new avenues to study the effects of these neuropeptides on the nervous system. Here we investigated the structure-activity relationships (SARs) of peptides derived from adrenocorticotropic hormone (ACTH) with cloned MC3 and MC4 receptors in vitro and correlated these with central effects of MCs in vivo. Analysis of the effects of various MC peptides on cAMP accumulation in and binding to cells that expressed either the rat MC3 receptor or the human MC4 receptor demonstrated that ACTH-4-9-NH2 was the core sequence of ACTH able to activate these receptors. Furthermore, gamma-melanocyte-stimulating hormone (MSH) displayed selectivity for the MC3 receptor, whereas [D-Phe7]ACTH-4-10 more efficiently activated the MC4 receptor than the MC3 receptor. The activities of MC fragments that lacked the three carboxyl-terminal amino acids (residues 11-13) of ACTH-1-13 were much lower than that of alpha-MSH, for both receptors. Furthermore, the three amino-terminal amino acids (residues 1-3) of alpha-MSH were more important for full activation of the MC4 receptor, compared with the MC3 receptor. The SAR for the MC4 receptor resembled that for the induction of excessive grooming behavior by MC peptides. Therefore, we suggest that this behavioral response is mediated by MC4 receptors. The SAR for the MC3 receptor did not overlap with that for in vivo effects of MCs. ORG2766, an ACTH-4-9 analog that is very potent in an active avoidance task, did not activate, antagonize, or bind to the MC3 and MC4 receptors. This suggests the presence of still other MC receptors, in addition to the MC3 and MC4 receptors, in the brain. These data identify peptides with selectivity for either the MC3 receptor or the MC4 receptor, which may be used for development of novel MC receptor-specific ligands. Furthermore, this is the first report that discusses behavioral effects of MCs in light of data on cloned MC receptors.

Volume 46, Issue 6, pp. 1182-1190, 12/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. L. Trevaskis, E. A. Meyer, J. E. Galgani, and A. A. Butler
Counterintuitive Effects of Double-Heterozygous Null Melanocortin-4 Receptor and Leptin Genes on Diet-Induced Obesity and Insulin Resistance in C57BL/6J Mice
Endocrinology, January 1, 2008; 149(1): 174 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Krude, H. Biebermann, D. Schnabel, M. Z. Tansek, P. Theunissen, P. E. Mullis, and A. Gruters
Obesity Due to Proopiomelanocortin Deficiency: Three New Cases and Treatment Trials with Thyroid Hormone and ACTH4-10
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4633 - 4640.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. J. Clegg, S. C. Benoit, E. L. Air, A. Jackman, P. Tso, D. D'Alessio, S. C. Woods, and R. J. Seeley
Increased Dietary Fat Attenuates the Anorexic Effects of Intracerebroventricular Injections of MTII
Endocrinology, July 1, 2003; 144(7): 2941 - 2946.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. J. Clegg, C. A. Riedy, K. A. B. Smith, S. C. Benoit, and S. C. Woods
Differential Sensitivity to Central Leptin and Insulin in Male and Female Rats
Diabetes, March 1, 2003; 52(3): 682 - 687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. J. Hwa, L. Ghibaudi, J. Gao, and E. M. Parker
Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R444 - R451.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. L. Fehm, R. Smolnik, W. Kern, G. P. McGregor, U. Bickel, and J. Born
The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4-10 Decreases Body Fat in Humans
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1144 - 1148.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
L. Langouche, M. Roudbaraki, K. Pals, and C. Denef
Stimulation of Intracellular Free Calcium in GH3 Cells by {{gamma}}3-Melanocyte-Stimulating Hormone. Involvement of a Novel Melanocortin Receptor?
Endocrinology, January 1, 2001; 142(1): 257 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. C. Benoit, M. W. Schwartz, J. L. Lachey, M. M. Hagan, P. A. Rushing, K. A. Blake, K. A. Yagaloff, G. Kurylko, L. Franco, W. Danhoo, et al.
A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences
J. Neurosci., May 1, 2000; 20(9): 3442 - 3448.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Fekete, G. Legradi, E. Mihaly, Q.-H. Huang, J. B. Tatro, W. M. Rand, C. H. Emerson, and R. M. Lechan
alpha -Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression
J. Neurosci., February 15, 2000; 20(4): 1550 - 1558.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. M. Hagan, P. A. Rushing, M. W. Schwartz, K. A. Yagaloff, P. Burn, S. C. Woods, and R. J. Seeley
Role of the CNS Melanocortin System in the Response to Overfeeding
J. Neurosci., March 15, 1999; 19(6): 2362 - 2367.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. J. Grill, A. B. Ginsberg, R. J. Seeley, and J. M. Kaplan
Brainstem Application of Melanocortin Receptor Ligands Produces Long-Lasting Effects on Feeding and Body Weight
J. Neurosci., December 1, 1998; 18(23): 10128 - 10135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. Ludwig, K. G. Mountjoy, J. B. Tatro, J. A. Gillette, R. C. Frederich, J. S. Flier, and E. Maratos-Flier
Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus
Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E627 - E633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-P. Ni, R. A. Kesterson, S. D. Sharma, V. J. Hruby, R. D. Cone, E. Wiedemann, and M. H. Humphreys
Prevention of reflex natriuresis after acute unilateral nephrectomy by melanocortin receptor antagonists
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R931 - R938.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S.-J. Li, K. Varga, P. Archer, V. J. Hruby, S. D. Sharma, R. A. Kesterson, R. D. Cone, and G. Kunos
Melanocortin Antagonists Define Two Distinct Pathways of Cardiovascular Control by alpha - and gamma -Melanocyte-Stimulating Hormones
J. Neurosci., August 15, 1996; 16(16): 5182 - 5188.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics